Table 2.
Distribution of AMA-positive samples of primary biliary cirrhosis patients and biochemically normal individuals according to the reactivity in multiple assays for autoantibodies

BN biochemically normal individuals, BN/AID biochemically normal individuals with some other autoimmune disease, PBC primary biliary cirrhosis, PBC/AID primary biliary cirrhosis plus other autoimmune disease
aBN/AID × PBC (p = 0.021)
bPBC × BN (p = 0.003); PBC/AID × BN (p = 0.004)
cPBC × BN (p = 0.023); PBC/AID × BN (p = 0.007)
d1 isotype: BN × PBC (p = 0.006) and BN × PBC/AID (p = 0.003); 3 isotypes: PBC × BN (p = 0.013) and PBC/AID × BN (p = 0.008)
eBN × PBC (p = 0.019) and BN × PBC/AID (p = 0.048)
fPBC × BN (p = 0.004)
gPBC/AID × PBC (p = 0.014); PBC/AID × BN (p < 0.001); PBC/AID × BN/AID (p = 0.021)
h1 cellular target: BN/AID × PBC/AID (p = 0.008); BN × PBC/AID (p = 0.003); ≥3 cellular targets PBC/AID × BN (p < 0.001); PBC/AID × BN/AID (p = 0.005); PBC × BN (p = 0.048)